Stock listing
Tradegate:1BT Enlivex Ltd. Aktie
German listing (Tradegate) of Enlivex Ltd. · home listing NASDAQ:ENLV
Follow Enlivex Ltd. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ENLV
$0.199 USD -0.003 (-1.5%)
Close on Oct 22, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ENLV
- Day range
- $0.192 – $0.205 USDOct 22, 2026
- Volume
- 479,749 sharesOct 22, 2026
- Market cap
- $3.97M USDAt the close on Oct 22, 2026 · price × 19.91M shares outstanding
- 52-week range
- $0.192 – $27.150 USDLowest and highest trades, Oct 23, 2025 – Oct 22, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ENLV · Home | $0.199 USD | -0.003 (-1.5%) | 479,749 | $0.196 | $0.205 | $0.192 | $0.202 | Close on Oct 22, 2026 |
| Frankfurt:1BT | €0.176 EUR | -0.020 (-10.2%) | — | €0.176 | €0.176 | €0.176 | €0.196 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Jul 22, 2026 – Oct 22, 2026 · NASDAQ:ENLV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.199 | -0.003 | -1.5% | $0.196 | $0.205 | $0.192 | 479,749 | |
| $0.202 | -0.022 | -9.6% | $0.223 | $0.230 | $0.200 | 738,320 | |
| $0.224 | +0.016 | +7.9% | $0.215 | $0.229 | $0.205 | 432,058 | |
| $0.207 | +0.002 | +1.2% | $0.211 | $0.227 | $0.193 | 593,722 | |
| $0.205 | -0.019 | -8.5% | $0.230 | $0.233 | $0.205 | 466,000 | |
| $0.224 | +0.008 | +3.7% | $0.220 | $0.236 | $0.210 | 557,800 | |
| $0.216 | -0.006 | -2.7% | $0.225 | $0.228 | $0.210 | 556,800 | |
| $0.222 | -0.031 | -12.3% | $0.259 | $0.260 | $0.221 | 868,400 | |
| $0.253 | -0.001 | -0.4% | $0.260 | $0.263 | $0.245 | 892,900 | |
| $0.254 | -0.023 | -8.3% | $0.250 | $0.283 | $0.224 | 2,783,800 | |
| $0.277 | -0.029 | -9.5% | $0.332 | $0.430 | $0.255 | 32,680,800 | |
| $0.306 | -0.034 | -10.0% | $0.352 | $0.352 | $0.300 | 3,898,800 | |
| $0.340 | -0.022 | -6.1% | $0.374 | $0.378 | $0.340 | 409,300 | |
| $0.362 | -0.025 | -6.5% | $0.400 | $0.408 | $0.361 | 423,200 | |
| $0.387 | -0.036 | -8.5% | $0.424 | $0.430 | $0.380 | 631,100 | |
| $0.423 | -0.080 | -15.9% | $0.492 | $0.502 | $0.411 | 755,100 | |
| $0.503 | +0.023 | +4.8% | $0.481 | $0.580 | $0.470 | 968,700 | |
| $0.480 | -0.034 | -6.6% | $0.520 | $0.530 | $0.470 | 585,800 | |
| $0.514 | -0.084 | -14.0% | $0.600 | $0.600 | $0.503 | 631,000 | |
| $0.598 | -0.008 | -1.3% | $0.600 | $0.620 | $0.580 | 316,000 | |
| $0.606 | -0.034 | -5.3% | $0.634 | $0.640 | $0.570 | 377,000 | |
| $0.640 | -0.006 | -0.9% | $0.633 | $0.687 | $0.615 | 593,600 | |
| $0.646 | -0.047 | -6.8% | $0.690 | $0.709 | $0.574 | 1,232,400 | |
| $0.693 | -0.114 | -14.1% | $0.840 | $0.850 | $0.665 | 668,800 | |
| $0.807 | +0.080 | +11.0% | $0.730 | $0.819 | $0.711 | 349,900 | |
| $0.727 | -0.084 | -10.4% | $0.821 | $0.851 | $0.640 | 762,000 | |
| $0.811 | -0.072 | -8.2% | $0.900 | $0.920 | $0.790 | 409,900 | |
| $0.883 | +0.018 | +2.1% | $0.880 | $0.920 | $0.870 | 229,400 | |
| $0.865 | -0.095 | -9.9% | $0.950 | $1.020 | $0.864 | 304,300 | |
| $0.960 | -0.021 | -2.1% | $1.000 | $1.070 | $0.950 | 246,300 | |
| $0.981 | -0.059 | -5.7% | $1.030 | $1.060 | $0.980 | 278,500 | |
| $1.040 | -0.070 | -6.3% | $1.120 | $1.217 | $1.020 | 287,200 | |
| $1.110 | +0.010 | +0.9% | $1.100 | $1.190 | $1.060 | 189,700 | |
| $1.100 | -0.060 | -5.2% | $1.150 | $1.160 | $1.020 | 251,100 | |
| $1.160 | -0.090 | -7.2% | $1.250 | $1.275 | $1.130 | 294,000 | |
| $1.250 | -0.030 | -2.3% | $1.290 | $1.300 | $1.210 | 227,500 | |
| $1.280 | 0.000 | 0.0% | $1.270 | $1.310 | $1.200 | 343,300 | |
| $1.280 | -0.070 | -5.2% | $1.330 | $1.340 | $1.150 | 400,100 | |
| $1.350 | -0.125 | -8.5% | $1.500 | $1.575 | $1.345 | 531,300 | |
| $1.475 | -0.040 | -2.6% | $1.510 | $1.660 | $1.470 | 517,400 | |
| $1.515 | -0.005 | -0.3% | $1.520 | $1.620 | $1.460 | 149,300 | |
| $1.520 | +0.010 | +0.7% | $1.490 | $1.570 | $1.460 | 161,600 | |
| $1.510 | +0.040 | +2.7% | $1.480 | $1.560 | $1.440 | 143,800 | |
| $1.470 | -0.030 | -2.0% | $1.490 | $1.520 | $1.390 | 154,800 | |
| $1.500 | -0.230 | -13.3% | $1.680 | $1.700 | $1.455 | 270,900 | |
| $1.730 | +0.210 | +13.8% | $1.500 | $1.810 | $1.470 | 295,100 | |
| $1.520 | -0.060 | -3.8% | $1.570 | $1.580 | $1.480 | 148,000 | |
| $1.580 | 0.000 | 0.0% | $1.590 | $1.620 | $1.540 | 174,600 | |
| $1.580 | -0.110 | -6.5% | $1.710 | $1.710 | $1.530 | 342,200 | |
| $1.690 | -0.150 | -8.2% | $1.940 | $1.980 | $1.680 | 451,600 | |
| $1.840 | -0.080 | -4.2% | $2.000 | $2.180 | $1.720 | 644,000 | |
| $1.920 | -0.090 | -4.5% | $2.020 | $2.095 | $1.890 | 185,300 | |
| $2.010 | -0.070 | -3.4% | $2.020 | $2.130 | $1.945 | 190,300 | |
| $2.080 | +0.100 | +5.1% | $1.980 | $2.137 | $1.900 | 202,000 | |
| $1.980 | -0.200 | -9.2% | $2.150 | $2.190 | $1.920 | 203,000 | |
| $2.180 | +0.070 | +3.3% | $2.070 | $2.260 | $1.980 | 286,700 | |
| $2.110 | -0.060 | -2.8% | $2.250 | $2.255 | $2.030 | 467,400 | |
| $2.170 | +0.080 | +3.8% | $2.140 | $2.323 | $2.110 | 273,300 | |
| $2.090 | +0.140 | +7.2% | $1.910 | $2.160 | $1.800 | 341,900 | |
| $1.950 | -0.300 | -13.3% | $2.250 | $2.250 | $1.920 | 314,600 | |
| $2.250 | +0.010 | +0.4% | $2.290 | $2.320 | $2.000 | 373,900 | |
| $2.240 | -2.020 | -47.4% | $3.260 | $3.260 | $2.080 | 4,039,200 | |
| $4.260 | +0.060 | +1.4% | $4.220 | $4.320 | $4.020 | 59,400 | |
| $4.200 | -0.160 | -3.7% | $4.360 | $4.470 | $4.080 | 106,600 | |
| $4.360 | -0.225 | -4.9% | $4.520 | $4.610 | $4.300 | 130,600 | |
| $4.585 | -0.145 | -3.1% | $4.650 | $4.830 | $4.535 | 65,600 |
- Ticker
- Tradegate:1BT
- Asset type
- Stock
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Oct 19, 2026
Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Latest deck · Jun 24, 2026
Investor Presentation (June 2026)
Investor deck · 25 slides
Latest news
Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Oct 19, 2026
Closed $0.207 (+1.2%) on Oct 19, 2026
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
Sep 22, 2026
Closed $0.646 (-6.8%) on Sep 22, 2026
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June
Jul 30, 2026
Closed $1.95 (-13.3%) on Jul 30, 2026
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
Jul 29, 2026
Closed $2.25 (+0.4%) on Jul 29, 2026
Enlivex Announces $400,000,000 Private Placement
Jul 28, 2026
Closed $2.24 (-47.4%) on Jul 28, 2026
Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion
Jul 20, 2026
Closed $4.64 (-0.9%) on Jul 20, 2026
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
Jul 13, 2026
Closed $6.67 (-2.8%) on Jul 13, 2026
Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026
Jul 7, 2026
Closed $7.41 (-3.5%) on Jul 7, 2026
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume
Jun 24, 2026
Closed $9.08 (-1.0%) on Jun 24, 2026
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion
Jun 22, 2026
Closed $9.35 (+0.2%) on Jun 22, 2026
Financings
Private placement of ordinary shares
Sep 22, 2026
Cancelled: US$400M · US$6 a share
Buyers: Rain Foundation (66,666,667 ordinary shares, to be paid for using RAIN tokens (agreement terminated))
Use of proceeds: Treasury strategy built around the Rain protocol prediction markets, while continuing to advance its Allocetra immunotherapy for age-related osteoarthritis
Decks
Investor Presentation (June 2026)
Investor deck · 25 slides · Jun 24, 2026
Investor Presentation (June 2026)
Investor deck · 35 slides · June 2026
Investor Presentation (March 2026)
Investor deck · 26 slides · Mar 24, 2026
Enlivex Therapeutics — Investor Presentation (November 2025)
Investor deck · 26 slides · Nov 24, 2025
Enlivex Ltd. on 6ix
- News releases
- 32 in the last 12 months · 145 in all · newest Oct 19, 2026 · oldest 2019
- Decks
- 32 decks · latest Jun 24, 2026
Where Enlivex Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ENLV · Home listing | NASDAQ | United States | USD |
| LS Exchange:A119KH | LS Exchange | Germany | EUR |
| Lang & Schwarz:A119KH | Lang & Schwarz | Germany | EUR |
| Frankfurt:1BT | Frankfurt | Germany | EUR |
| Tradegate:1BT · This page | Tradegate | Germany | EUR |
| BOATS:ENLV | BOATS | United States | USD |
| Stuttgart:1BT | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Enlivex Ltd.